Apr 28 2026FINANCE
Breathing Room for a Biotech Firm’s Big Plans
A French biotech company just got a two-year break from paying back millions in loans, giving it more cash to push forward on cutting-edge research. The firm, known for developing treatments targeting tough diseases, reached a deal with lenders to delay loan payments totaling around €17. 8 million.
reading time less than a minute
